Scientists at the Texas Biomedical Research Institute have discovered a medication that significantly decreases the growth of tuberculosis (TB), especially in drug-resistant bacteria. The medication, which is a combination of two molecules, has been successful in initiating natural cell death processes in TB-infected human cells. TB kills over 1.6 million people annually, and drug resistance is making treatment more difficult. The researchers believe that host-directed therapies, like this medication, can be a game-changer for infectious diseases.
Scientists at the Texas Biomedical Research Institute have discovered a medication that significantly decreases the growth of tuberculosis (TB), especially in drug-resistant bacteria. The medication, which is a combination of two molecules, has been successful in initiating natural cell death processes in TB-infected human cells. TB kills over 1.6 million people annually, and drug resistance is making treatment more difficult. The researchers believe that host-directed therapies, like this medication, can be a game-changer for infectious diseases.
टिप्पणियाँ
एक टिप्पणी भेजें